Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Secures $3M Loan, Discloses Trial Date for Alnylam Litigation

Premium

Tekmira Pharmaceuticals said this week that it has secured a $3 million loan, extending its cash runway into 2013.

Separately this week, Tekmira announced that a trial date of Oct. 30, 2012 has been set for its litigation with Alnylam Pharmaceuticals and AlCana Technologies.

According to the company, Silicon Valley Bank has agreed to provide a $3 million term loan, which can be drawn down at Tekmira's discretion at any time before Sept. 30, 2012. The loan matures on June 30, 2015, and carries a fixed annual interest rate of 8 percent.

Tekmira said it has provided the bank with 54,545 warrants at a price of $1.65 each, and will provide additional warrants equal to 2 percent of any draw-down on the loan. Tekmira said it plans to use the funds to support its drug-development efforts and for general corporate purposes.

Meantime, the company's lawsuit against Alnylam and AlCana is proceeding apace, and the court's establishment of a specific trial date “removes any uncertainty about the timeline,” according to a statement from Tekmira President and CEO Mark Murray.

Tekmira sued Alnylam earlier this year for allegedly misappropriating trade secrets related to its proprietary siRNA-delivery technologies (GSN 3/17/2011). Tekmira later expanded its suit to include AlCana.

Both defendants have filed counterclaims.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.